Van Hulzen Asset Management’s Edwards Lifesciences EW Stock Holding History

Van Hulzen Asset Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.21M	Buy	35,500 +1,476	+4%	+$124K	0.23%	88
2026 Q1	$2.72M	Hold	34,024	–	–	0.2%	86
2025 Q4	$2.9M	Hold	34,024	–	–	0.21%	83
2025 Q3	$2.65M	Sell	34,024 -15	-0%	-$1.17K	0.2%	85
2025 Q2	$2.66M	Buy	34,039 +39	+0.1%	+$2.91K	0.22%	83
2025 Q1	$2.46M	Sell	34,000 -132	-0.4%	-$9.45K	0.22%	86
2024 Q4	$2.53M	Buy	34,132 +132	+0.4%	+$9.24K	0.18%	97
2024 Q3	$2.24M	Hold	34,000	–	–	0.16%	104
2024 Q2	$3.14M	Sell	34,000 -2,110	-6%	-$187K	0.21%	78
2024 Q1	$3.45M	Buy	36,110 +110	+0.3%	+$9.24K	0.23%	82
2023 Q4	$2.75M	Hold	36,000	–	–	0.19%	86
2023 Q3	$2.49M	Hold	36,000	–	–	0.19%	86
2023 Q2	$3.4M	Hold	36,000	–	–	0.29%	70
2023 Q1	$2.98M	Sell	36,000 -80	-0.2%	-$6.29K	0.28%	71
2022 Q4	$2.69M	Sell	36,080 -400	-1%	-$30.8K	0.31%	71
2022 Q3	$3.01M	Sell	36,480 -300	-0.8%	-$28.9K	0.37%	67
2022 Q2	$3.5M	Buy	36,780 +80	+0.2%	+$8.28K	0.42%	64
2022 Q1	$4.32M	Hold	36,700	–	–	0.46%	61
2021 Q4	$4.75M	Buy	+36,700	New	+$4.28M	0.52%	55

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Van Hulzen Asset Management's EW Position: Q2 2026 in Review

Van Hulzen Asset Management increased its Edwards Lifesciences (EW) stake by 4.3% in Q2 2026, buying an estimated $124K and bringing the position to 35,500 shares worth $3.21M. The position accounts for 0.23% of the portfolio, ranked #88.

Van Hulzen Asset Management first reported a position in EW in Q4 2021 and has held it in 19 quarters since. The position peaked at $4.75M in Q4 2021. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Van Hulzen Asset Management held 35,500 shares of Edwards Lifesciences worth $3.21M as of Q2 2026.
Van Hulzen Asset Management bought 1,476 Edwards Lifesciences shares in Q2 2026, an estimated $124K.
Edwards Lifesciences made up 0.23% of Van Hulzen Asset Management's portfolio in Q2 2026, its #88 holding.
Van Hulzen Asset Management first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 19 quarters since.
Van Hulzen Asset Management's Edwards Lifesciences position peaked at $4.75M in Q4 2021.
1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Van Hulzen Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.